Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Tuberculosis

  Free Subscription


Articles published in Infect Immun

Retrieve available abstracts of 40 articles:
HTML format



Single Articles


    February 2020
  1. ANKLEY L, Thomas S, Olive AJ
    Fighting persistence; how chronic infections with Mycobacterium tuberculosis evade T cell-mediated clearance and new strategies to defeat them.
    Infect Immun. 2020 Feb 24. pii: IAI.00916-19. doi: 10.1128/IAI.00916.
    PubMed     Abstract available


    December 2019
  2. RUIZ-TAGLE C, Naves R, Balcells ME
    Unraveling the role of microRNAs in Mycobacterium tuberculosis infection and disease: advances and pitfalls.
    Infect Immun. 2019 Dec 23. pii: IAI.00649-19. doi: 10.1128/IAI.00649.
    PubMed     Abstract available


  3. KENNEDY JM, Georges A, Bassenden AV, Vidal SM, et al
    ZBTB7B (ThPOK) IS REQUIRED FOR PATHOGENESIS OF CEREBRAL MALARIA AND PROTECTION AGAINST PULMONARY TUBERCULOSIS.
    Infect Immun. 2019 Dec 2. pii: IAI.00845-19. doi: 10.1128/IAI.00845.
    PubMed     Abstract available


    October 2019
  4. YANG D, Li S, Stabenow J, Zalduondo L, et al
    Mycobacterium tuberculosis LipE has a lipase/esterase activity and is important for intracellular growth and in vivo infection.
    Infect Immun. 2019 Oct 21. pii: IAI.00750-19. doi: 10.1128/IAI.00750.
    PubMed     Abstract available


  5. HERNANDEZ PANDO R, Shin SJ, Clark S, Casonato S, et al
    Construction and characterization of the double unmarked Mycobacterium tuberculosis mutant sigE/fadD26 as a vaccine candidate.
    Infect Immun. 2019 Oct 7. pii: IAI.00496-19. doi: 10.1128/IAI.00496.
    PubMed     Abstract available


    September 2019
  6. AHMAD S, Bhattacharya D, Kar S, Ranganathan A, et al
    Curcumin Nanoparticles Enhance BCG Vaccine Efficacy by Modulating Host Immune Responses.
    Infect Immun. 2019 Sep 3. pii: IAI.00291-19. doi: 10.1128/IAI.00291.
    PubMed     Abstract available


  7. HOFT SG, Sallin MA, Kauffman KD, Sakai S, et al
    Erratum for Hoft et al., "The Rate of CD4 T Cell Entry into the Lungs during Mycobacterium tuberculosis Infection Is Determined by Partial and Opposing Effects of Multiple Chemokine Receptors".
    Infect Immun. 2019;87.
    PubMed    


    April 2019
  8. HOFT SG, Sallin MA, Kauffman KD, Sakai S, et al
    The rate of CD4 T cell entry into the lungs during Mycobacterium tuberculosis infection is determined by partial and opposing effects of multiple chemokine receptors.
    Infect Immun. 2019 Apr 8. pii: IAI.00841-18. doi: 10.1128/IAI.00841.
    PubMed     Abstract available


    January 2019
  9. RAFFETSEDER J, Iakobachvili N, Loitto V, Peters PJ, et al
    Retention of EsxA in the capsule-like layer of Mycobacterium tuberculosis is associated with cytotoxicity and is counteracted by lung surfactant.
    Infect Immun. 2019 Jan 2. pii: IAI.00803-18. doi: 10.1128/IAI.00803.
    PubMed     Abstract available


    December 2018
  10. GOPALAKRISHNAN A, Dietzold J, Verma S, Bhagavathula M, et al
    Toll-like receptor 2 prevents neutrophil-driven immunopathology during infection with Mycobacterium tuberculosis by curtailing CXCL5 production.
    Infect Immun. 2018 Dec 17. pii: IAI.00760-18. doi: 10.1128/IAI.00760.
    PubMed     Abstract available


    November 2018
  11. TULLIUS MV, Nava S, Horwitz MA
    PPE37 is essential for Mycobacterium tuberculosis heme-iron acquisition (HIA) and a defective PPE37 in Mycobacterium bovis BCG prevents HIA.
    Infect Immun. 2018 Nov 19. pii: IAI.00540-18. doi: 10.1128/IAI.00540.
    PubMed     Abstract available


  12. ELLIOTT SR, White DW, Tischler AD
    Mycobacterium tuberculosis Requires Regulation of ESX-5 Secretion for Virulence in Irgm1-Deficient Mice.
    Infect Immun. 2018 Nov 19. pii: IAI.00660-18. doi: 10.1128/IAI.00660.
    PubMed     Abstract available


  13. SOMA S, Kawai S, Inada H, Watanabe K, et al
    Primary Role of Suppressor of Cytokine Signaling 1 in Mycobacterium bovis BCG Infection.
    Infect Immun. 2018;86.
    PubMed     Abstract available


    September 2018
  14. RODGERS MA, Ameel C, Ellis-Connell AL, Balgeman AJ, et al
    Pre-existing SIV Infection Increases Susceptibility to Tuberculosis in Mauritian Cynomolgus Macaques.
    Infect Immun. 2018 Sep 17. pii: IAI.00565-18. doi: 10.1128/IAI.00565.
    PubMed     Abstract available


  15. KAUFFMAN KD, Sallin MA, Hoft SG, Sakai S, et al
    Limited pulmonary mucosal-associated invariant T cell accumulation and activation during Mycobacterium tuberculosis infection in rhesus macaques.
    Infect Immun. 2018 Sep 10. pii: IAI.00431-18. doi: 10.1128/IAI.00431.
    PubMed     Abstract available


  16. SANTUCCI P, Diomande S, Poncin I, Alibaud L, et al
    Delineating the Physiological Roles of the PE and Catalytic Domains of LipY in Lipid Consumption in Mycobacterium-Infected Foamy Macrophages.
    Infect Immun. 2018;86.
    PubMed     Abstract available


    August 2018
  17. MANI R, Gupta M, Malik A, Tandon R, et al
    Adjuvant Potential of Poly-alpha-L-glutamine from Cell Wall of Mycobacterium tuberculosis.
    Infect Immun. 2018 Aug 13. pii: IAI.00537-18. doi: 10.1128/IAI.00537.
    PubMed     Abstract available


  18. NOGUCHI N, Nakamura R, Hatano S, Yamada H, et al
    Interleukin-21 Induces Short-Lived Effector CD8(+) T Cells but Does Not Inhibit Their Exhaustion after Mycobacterium bovis BCG Infection in Mice.
    Infect Immun. 2018;86.
    PubMed     Abstract available


    July 2018
  19. SHUKLA S, Richardson ET, Drage MG, Boom WH, et al
    Mycobacterium tuberculosis lipoprotein and lipoglycan binding to Toll-like receptor 2 correlates with agonist activity and functional outcomes.
    Infect Immun. 2018 Jul 23. pii: IAI.00450-18. doi: 10.1128/IAI.00450.
    PubMed     Abstract available


    June 2018
  20. KENNEDY SC, Johnson AJ, Bharrhan S, Lindestam Arlehamn CS, et al
    Identification of mycobacterial ribosomal proteins as targets for CD4(+) T cells that enhance protective immunity in tuberculosis.
    Infect Immun. 2018 Jun 11. pii: IAI.00009-18. doi: 10.1128/IAI.00009.
    PubMed     Abstract available


  21. WONG EA, Joslyn L, Grant NL, Klein E, et al
    Low levels of T cell exhaustion in tuberculous lung granulomas.
    Infect Immun. 2018 Jun 11. pii: IAI.00426-18. doi: 10.1128/IAI.00426.
    PubMed     Abstract available


    April 2018
  22. STYLIANOU E, Harrington-Kandt R, Beglov J, Bull N, et al
    Identification and Evaluation of Novel Protective Antigens for the Development of a Candidate TB Subunit Vaccine.
    Infect Immun. 2018 Apr 16. pii: IAI.00014-18. doi: 10.1128/IAI.00014.
    PubMed     Abstract available


  23. MOIDEEN K, Kumar NP, Nair D, Banurekha VV, et al
    Heightened systemic levels of neutrophil and eosinophil granular proteins in pulmonary tuberculosis and reversal following treatment.
    Infect Immun. 2018 Apr 9. pii: IAI.00008-18. doi: 10.1128/IAI.00008.
    PubMed     Abstract available


  24. NANDY A, Mondal AK, Pandey R, Arumugam P, et al
    Adipocyte model of Mycobacterium tuberculosis infection reveals differential iron availability to bacilli in the lipid rich caseous environment.
    Infect Immun. 2018 Apr 9. pii: IAI.00041-18. doi: 10.1128/IAI.00041.
    PubMed     Abstract available


    March 2018
  25. JENSEN K, Gallagher IJ, Johnston N, Welsh M, et al
    Variation in the Early Host-Pathogen Interaction of Bovine Macrophages with Divergent Mycobacterium bovis Strains in the United Kingdom.
    Infect Immun. 2018;86.
    PubMed     Abstract available


    January 2018
  26. TEKLU T, Keehwan K, Wondale B, HaileMariam M, et al
    Potential immunological biomarkers for detection of Mycobacterium tuberculosis infection in endemic setting, Ethiopia.
    Infect Immun. 2018 Jan 8. pii: IAI.00759-17. doi: 10.1128/IAI.00759.
    PubMed     Abstract available


    December 2017
  27. LADDY DJ, Bonavia A, Hanekom WA, Kaushal D, et al
    Toward Tuberculosis Vaccine Development: Recommendations for NHP Study Design.
    Infect Immun. 2017 Dec 4. pii: IAI.00776-17. doi: 10.1128/IAI.00776.
    PubMed     Abstract available


    November 2017
  28. GEORGIEVA M, Sia JK, Bizzell E, Madan-Lala R, et al
    Mycobacterium tuberculosis GroEL2 modulates dendritic cell responses.
    Infect Immun. 2017 Nov 13. pii: IAI.00387-17. doi: 10.1128/IAI.00387.
    PubMed     Abstract available


    October 2017
  29. PURDY GE
    Reply to Brennan, "Biofilms and Mycobacterium tuberculosis".
    Infect Immun. 2017;85.
    PubMed    


  30. BRENNAN MJ
    Biofilms and Mycobacterium tuberculosis.
    Infect Immun. 2017;85.
    PubMed    


    September 2017
  31. MAIELLO P, DiFazio RM, Cadena AM, Rodgers MA, et al
    Rhesus macaques are more susceptible to progressive tuberculosis than cynomolgus macaques: A quantitative comparison.
    Infect Immun. 2017 Sep 25. pii: IAI.00505-17. doi: 10.1128/IAI.00505.
    PubMed     Abstract available


  32. BOUZID F, Bregeon F, Lepidi H, Donoghue HD, et al
    Ready experimental translocation of Mycobacterium canettii yields pulmonary tuberculosis.
    Infect Immun. 2017 Sep 18. pii: IAI.00507-17. doi: 10.1128/IAI.00507.
    PubMed     Abstract available


    July 2017
  33. NAIK SK, Padhi A, Ganguli G, Sengupta S, et al
    Mice bone marrow Sca-1+/CD44+mesenchymal stem cells kill avirulent mycobacteria but not Mycobacterium tuberculosis through modulation of cathelicidin expression via p38 MAPK dependent pathway.
    Infect Immun. 2017 Jul 24. pii: IAI.00471-17. doi: 10.1128/IAI.00471.
    PubMed     Abstract available


    June 2017
  34. JIA Q, Dillon BJ, Maslesa-Galic S, Horwitz MA, et al
    Listeria-vectored vaccine expressing the Mycobacterium tuberculosis 30 kDa major secretory protein via the constitutively active prfA* regulon boosts BCG efficacy against tuberculosis.
    Infect Immun. 2017 Jun 19. pii: IAI.00245-17. doi: 10.1128/IAI.00245.
    PubMed     Abstract available


    May 2017
  35. WRIGHT CC, Hsu FF, Arnett E, Dunaj JL, et al
    The Mycobacterium tuberculosis MmpL11 cell wall lipid transporter is important for biofilm formation, intracellular growth and non-replicating persistence.
    Infect Immun. 2017 May 15. pii: IAI.00131-17. doi: 10.1128/IAI.00131.
    PubMed     Abstract available


    April 2017
  36. JOHNSON AJ, Kennedy SC, Lindestam Arlehamn CS, Goldberg MF, et al
    Identification of Mycobacterial RplJ/L10 and RpsA/S1 Proteins as Novel Targets for CD4+ T Cells.
    Infect Immun. 2017;85.
    PubMed     Abstract available


    March 2017
  37. BRENNAN MJ
    The enigmatic PE/PPE Multi-gene Family of Mycobacteria and TB Vaccination.
    Infect Immun. 2017 Mar 27. pii: IAI.00969-16. doi: 10.1128/IAI.00969.
    PubMed     Abstract available


    February 2017
  38. ANURADHA R, Munisankar S, Bhootra Y, Dolla C, et al
    Anthelmintic therapy modifies the systemic and mycobacterial-antigen-stimulated cytokine profile in helminth-latent Mycobacterium tuberculosis co-infection.
    Infect Immun. 2017 Feb 6. pii: IAI.00973-16. doi: 10.1128/IAI.00973.
    PubMed     Abstract available


    January 2017
  39. ELLIS A, Balgeman A, Rodgers M, Updike C, et al
    Characterization of T cells specific for CFP-10 and ESAT-6 in M. tuberculosis-infected Mauritian Cynomolgus Macaques.
    Infect Immun. 2017 Jan 23. pii: IAI.01009-16. doi: 10.1128/IAI.01009.
    PubMed     Abstract available


  40. TORRES-HUERTA A, Villasenor T, Flores-Alcantar A, Parada C, et al
    THE INTERACTION OF THE CD43 SIALOMUCIN WITH THE MYCOBACTERIUM TUBERCULOSIS CPN60.2 CHAPERONIN MEDIATES MACROPHAGE TNF-alpha PRODUCTION.
    Infect Immun. 2017 Jan 9. pii: IAI.00915-16. doi: 10.1128/IAI.00915.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: